HUGHES & COMPANY
HUGHES & COMPANY is a Series C+ and buyout fund in the US writing $5M–$50M checks into Enterprise and healthcare-tech.
- Stages
- Series C+, buyout
- Sectors
- Enterprise, healthcare-tech
- Check size
- $5M–$50M
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2010
- Assets under management
- $116M, $260M
Thesis
Hughes & Company is a private equity firm founded in 2010, headquartered in Chicago, Illinois, specializing in the healthcare software and technology-enabled services sector. Their strategy involves active, hands-on investment, providing growth capital through recapitalizations, growth equity, and buyouts, with a typical investment range of $5 million to $50 million+. They avoid clinical services, pre-revenue companies, pharmaceuticals, biotechnology, and highly capital-intensive businesses. The firm has raised two funds, with Hughes Growth Equity Fund I closing at $116 million and Hughes Growth Equity Fund II closing at $260 million. They focus on companies with annual revenues between $5 million and $30 million and approximately $10 million in EBITDA. Their geographic focus is the United States. They aim to create value through revenue and EBITDA growth, leveraging their network and operational expertise.
Common questions
Does HUGHES & COMPANY invest at the Series C+ stage?
Yes. HUGHES & COMPANY lists Series C+ and buyout among the stages it invests in.
What check size does HUGHES & COMPANY write?
HUGHES & COMPANY writes $5M–$50M checks.
Where does HUGHES & COMPANY invest?
HUGHES & COMPANY invests in the US.